Clinical Trial Update: 6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis [NA]

View source ↗

Summary

A clinical trial is evaluating the six-month efficacy and safety of Synolis VA 80/160 for hip osteoarthritis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Hip

Drugs mentioned

• Synolis VA 80/160

Snippet

Sponsor: Aptissen SA | Conditions: Osteoarthritis, Hip | NA | Status: RECRUITING